Is CDNA Overvalued？
CDNA is now in the Fair zone, suggesting that
CDNA current forward PE ratio of 31.24 is considered
Fair compare with the five-year average of 56.64.
P/E
EV/EBITDA
P/S
P/B
P/E
P/E
CDNA Competitors Valuation Multiple
P/E
EV/EBITDA
P/S
P/E
P/E Multiple
Earnings Growth
Market Cap
CDNA Revenue Breakdown & PS Ratio Relation
Currency:USD
By Business
By Region
Composition (FY2024Q3)
Name
Revenue
Percentage
Testing Service revenue
60.81M
73.36%
Digital and other revenue
11.86M
14.31%
Product revenue
10.21M
12.32%
CDNA FAQs
Is CDNA currently overvalued based on its P/E ratio?
According to the provided data, CDNA's 5-year historical average forward P/E ratio is 56.68. CDNA forward P/E ratio is 31.24, which is categorized as Fair.
What is the significance of the EV/EBITDA ratio for CDNA?
How has CDNA's Price to Sales (PS) ratio evolved?
What are the key indicators to watch for CDNA's financial performance?
CDNA PE Ratio
Fair
5Y Average PE
56.64
Current PE
31.24
Overvalued PE
270.53
Undervalued PE
-157.25
CDNA EV/EBITDA Ratio
Fair
5Y Average EV
33.88
Current EV
26.01
Overvalued EV
165.85
Undervalued EV
-98.08
CDNA P/S Ratio
Fair
5Y Average PS
5.80
Current PS
2.82
Overvalued PS
10.10
Undervalued PS
1.51
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
At what price is CDNA undervalued？Is CDNA overvalued compared to its competitors？Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
At what price is CDNA undervalued？Is CDNA overvalued compared to its competitors？